US Patent 11219674 Therapeutic cancer vaccine
Patent 11219674 was granted and assigned to Cadila Pharmaceuticals on January, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11219674 Therapeutic cancer vaccine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.